Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment
Non-Hodgkin’s lymphoma (NHL) accounts for 60% of childhood lymphomas and is the fourth most common childhood malignancy. Burkitt’s lymphoma (BL) accounts for 40% of NHLs. Burkitt’s lymphoma is mostly of abdominal origin and has the highest cell count doubling rate. Tuberculosis (TB) is one of the ch...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2023-06-01
|
Series: | Haseki Tıp Bülteni |
Subjects: | |
Online Access: |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/tuberculosis-pleurisy-in-a-case-of-burkitt-lymphom/60803
|
_version_ | 1827908097828454400 |
---|---|
author | Huseyin Avni Solgun Seyma Acikgoz Duygu Ozkorucu Yildirgan Ozlem Terzi Ali Aycicek |
author_facet | Huseyin Avni Solgun Seyma Acikgoz Duygu Ozkorucu Yildirgan Ozlem Terzi Ali Aycicek |
author_sort | Huseyin Avni Solgun |
collection | DOAJ |
description | Non-Hodgkin’s lymphoma (NHL) accounts for 60% of childhood lymphomas and is the fourth most common childhood malignancy. Burkitt’s lymphoma (BL) accounts for 40% of NHLs. Burkitt’s lymphoma is mostly of abdominal origin and has the highest cell count doubling rate. Tuberculosis (TB) is one of the chronic diseases caused by the Mycobacterium tuberculosis bacillus, which has high morbidity and mortality and occurs most frequently in the lung. In this case report, we present a patient with a previous diagnosis of BL who developed pleural effusion while under rituximab-ifosfamide carboplatin etoposide treatment, and TB polymerase chain reaction (PCR) was revealed to be positive in the TB PCR screening test of the pleural fluid. To our knowledge, there is no previous study of the coexistence of BL and TB pleurisy in the literature. When pleural effusion develops in patients with BL under chemotherapy treatment, it should be kept in mind that TB may be present, and anti-TB treatment should be started as soon as the diagnosis is made. There is limited information in the literature about the frequency of tuberculous pleurisy in patients with BL. |
first_indexed | 2024-03-13T01:17:14Z |
format | Article |
id | doaj.art-282281d3328848f9ac548eb14f161a47 |
institution | Directory Open Access Journal |
issn | 1302-0072 2147-2688 |
language | English |
last_indexed | 2024-03-13T01:17:14Z |
publishDate | 2023-06-01 |
publisher | Galenos Yayinevi |
record_format | Article |
series | Haseki Tıp Bülteni |
spelling | doaj.art-282281d3328848f9ac548eb14f161a472023-07-05T08:52:23ZengGalenos YayineviHaseki Tıp Bülteni1302-00722147-26882023-06-0161321021310.4274/haseki.galenos.2023.906213049054Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab TreatmentHuseyin Avni Solgun0Seyma Acikgoz1Duygu Ozkorucu Yildirgan2Ozlem Terzi3Ali Aycicek4 University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Clinic of Pediatric Hematology and Oncology, Istanbul, Turkey University of Health Sciences Turkey, Istanbul Haseki Training and Research Hospital, Clinic of Pediatrics, Istanbul, Turkey University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Clinic of Pediatric Hematology and Oncology, Istanbul, Turkey University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Clinic of Pediatric Hematology and Oncology, Istanbul, Turkey University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Clinic of Pediatric Hematology and Oncology, Istanbul, Turkey Non-Hodgkin’s lymphoma (NHL) accounts for 60% of childhood lymphomas and is the fourth most common childhood malignancy. Burkitt’s lymphoma (BL) accounts for 40% of NHLs. Burkitt’s lymphoma is mostly of abdominal origin and has the highest cell count doubling rate. Tuberculosis (TB) is one of the chronic diseases caused by the Mycobacterium tuberculosis bacillus, which has high morbidity and mortality and occurs most frequently in the lung. In this case report, we present a patient with a previous diagnosis of BL who developed pleural effusion while under rituximab-ifosfamide carboplatin etoposide treatment, and TB polymerase chain reaction (PCR) was revealed to be positive in the TB PCR screening test of the pleural fluid. To our knowledge, there is no previous study of the coexistence of BL and TB pleurisy in the literature. When pleural effusion develops in patients with BL under chemotherapy treatment, it should be kept in mind that TB may be present, and anti-TB treatment should be started as soon as the diagnosis is made. There is limited information in the literature about the frequency of tuberculous pleurisy in patients with BL. http://www.hasekidergisi.com/archives/archive-detail/article-preview/tuberculosis-pleurisy-in-a-case-of-burkitt-lymphom/60803 burkitt’s lymphomatuberculosispleural effusiontuberculous pleurisyrituksimab |
spellingShingle | Huseyin Avni Solgun Seyma Acikgoz Duygu Ozkorucu Yildirgan Ozlem Terzi Ali Aycicek Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment Haseki Tıp Bülteni burkitt’s lymphoma tuberculosis pleural effusion tuberculous pleurisy rituksimab |
title | Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment |
title_full | Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment |
title_fullStr | Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment |
title_full_unstemmed | Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment |
title_short | Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment |
title_sort | tuberculosis pleurisy in a case of burkitt lymphoma secondary to rituksimab treatment |
topic | burkitt’s lymphoma tuberculosis pleural effusion tuberculous pleurisy rituksimab |
url |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/tuberculosis-pleurisy-in-a-case-of-burkitt-lymphom/60803
|
work_keys_str_mv | AT huseyinavnisolgun tuberculosispleurisyinacaseofburkittlymphomasecondarytorituksimabtreatment AT seymaacikgoz tuberculosispleurisyinacaseofburkittlymphomasecondarytorituksimabtreatment AT duyguozkorucuyildirgan tuberculosispleurisyinacaseofburkittlymphomasecondarytorituksimabtreatment AT ozlemterzi tuberculosispleurisyinacaseofburkittlymphomasecondarytorituksimabtreatment AT aliaycicek tuberculosispleurisyinacaseofburkittlymphomasecondarytorituksimabtreatment |